Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
0.860
+0.041 (4.94%)
Feb 24, 2025, 11:55 AM EST - Market open
Tiziana Life Sciences Employees
Tiziana Life Sciences had 9 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,525,333
Market Cap
93.86M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
TLSA News
- 3 days ago - Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC - GlobeNewsWire
- 6 days ago - Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program - GlobeNewsWire
- 13 days ago - Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer's Disease - GlobeNewsWire
- 4 weeks ago - Tiziana Life Sciences Announces Positive Results in Treating Spinal Cord Injury With Nasal Anti-CD3 - GlobeNewsWire
- 4 weeks ago - Tiziana Life Sciences not to engage in capital raising activities for the immediate future - GlobeNewsWire
- 4 weeks ago - Tiziana Life Sciences Announces Discovery of New Immune Biomarkers in Multiple Sclerosis Patients Treated with Nasal Foralumab - GlobeNewsWire
- 6 weeks ago - Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease - GlobeNewsWire
- 4 months ago - Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data - GlobeNewsWire